Circulating tumor DNA (ctDNA) as a marker of recurrence risk in stage II colon cancer (CC).
Year: 2014
Type: conference-abstract
Source: Journal of Clinical Oncology
Institutions: Walter and Eliza Hall Institute of Medical Research, Johns Hopkins University, Johns Hopkins Medicine, The Royal Melbourne Hospital, Western Hospital, Eastern Health, Box Hill Hospital, Sidney Kimmel Comprehensive Cancer Center, Australian National University, Canberra Hospital, Albury Wodonga Health, The Alfred Hospital, Ludwig Cancer Research
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2734433694
